Results 31 to 40 of about 11,904 (210)

Effect of Rivastigmine on Behavioral and Psychiatric Symptoms of Parkinson’s Disease Dementia [PDF]

Journal of Movement Disorders, 2015
Objective A recent study showed that rivastigmine and memantin improved behavioral and psychiatric symptoms of dementia (BPSD) in Alzheimer’s dementia. Furthermore, according to recent guidelines presented by the Movement Disorder Society, rivastigmine ...
Yoon-Sang Oh, Joong-Seok Kim, Phil Hyu Lee   +2 more
doaj   +1 more source

Development of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry (HPLC-MS/MS) Method to Determine the Presence of Rivastigmine in Human Plasma in Clinical Studies of Comparative Pharmacokinetics

Антибиотики и Химиотерапия, 2023
The basis for conducting bioequivalence studies is the determination of the bioavailability of the active substance of the drug at its place of action by establishing the concentration of the drug in biological fluids using sensitive analytical techniques.
M. S. Dolov, L. A. Fishgoit, P. D. Sobolev, E. P. Tkach   +3 more
doaj   +1 more source

Pharmacokinetics analysis of berberine and Rivastigmine.

, 2023
Pharmacokinetics analysis of berberine and Rivastigmine.
Muhammad Zeeshan Bhatti (17319727), Ihsan-ul Haq (5344400), Dania Khalid (13862216), Erum Dilshad (804537), Durdana Waseem (17319724), Muhammad Umar Ijaz (9960983), Hammad Ismail (4227988), Sadaf Anwaar (9105359), Madiha Ahmed (5344409), Samreen Saleem (17319730)   +9 more
core   +1 more source

Antimuscarinic delirium in a pediatric patient reversed with transdermal rivastigmine: A case report

JEM Reports
Background: Antidotal treatment of antimuscarinic delirium (AMD) standardly involves parenteral administration of physostigmine. However, due to cessation of physostigmine production, administration of oral or transdermal rivastigmine may serve as a ...
Natalie E. Ebeling-Koning, Natalie A. Burkert, Laura Koons, John D. Lindmark, Anthony F. Pizon, Kenneth D. Katz   +5 more
doaj   +1 more source

Ambient technology in epilepsy clinical practice

Epilepsia Open, EarlyView.
Abstract The utilization of large language model‐based artificial intelligence (AI) in the field of neurology has gained attention as a viable tool to enhance and assist providers with processes ranging from scheduling patients to providing preliminary interpretations of testing results, pending orders, and documenting encounters. Epileptologists could
Haania Kakwan, Justin F. Rousseau, Lidia M. Moura, Irfan S. Sheikh   +3 more
wiley   +1 more source

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background As Parkinson's disease (PD) progresses, motor fluctuations become increasingly difficult to manage with oral medications. Foslevodopa/foscarbidopa (LDp/CDp), delivered as a continuous 24‐h/day subcutaneous infusion, offers continuous levodopa delivery and stable plasma levodopa levels that reduce motor fluctuations. LDp/CDp has been
K. Ray Chaudhuri, Bruno Bergmans, Eric Freire‐Alvarez, Lucie Hopes, Drew S. Kern, Robert S. Kirsner, Giulia Lazzeri, Pedro Mendes‐Bastos, Noriko Nishikawa, Per Odin, Karolina Poplawska‐Domaszewicz, Rajesh Pahwa, Yuval Ramot, Klaus Seppi, Tobias Warnecke, Robert Wiggins, Megha B. Shah, Pavnit Kukreja, Bjoern Fritz, Koray Onuk, Stuart H. Isaacson   +20 more
wiley   +1 more source

Rivastigmine effects on EEG spectra and three-dimensional LORETA functional imaging in Alzheimer’s disease [PDF]

, 2008
OBJECTIVE: The objective of the study is to investigate the electrocortical and the global cognitive effects of 3 months rivastigmine medication in a group of mild to moderate Alzheimer's disease patients.
Gianotti, Lorena, Pascual-Marqui, R D, Pascual-Marqui, Roberto D, Pascual-Marqui, Roberto D., Künig, Gabriella, Faber, Pascal L, Schreiter-Gasser, U, Lehmann, Dietrich, Kochi, K, Schreiter-Gasser, Ursula, Gianotti, L R R, Kochi, Kieko, Lehmann, D, Faber, P L, Künig, G, Gianotti, Lorena R. R., Faber, Pascal L.   +16 more
core   +1 more source

Serum Concentrations of Cholinesterase Inhibitors in Patients With Alzheimer’s Dementia Are Frequently Below the Recommended Levels

Frontiers in Pharmacology, 2020
BackgroundAcetylcholinesterase inhibitors (AChE-I) are recommended for the treatment of cognitive symptoms but also of behavioral and psychological symptoms in dementia.
Marion Ortner, Marion Stange, Heike Schneider, Charlotte Schroeder, Katharina Buerger, Katharina Buerger, Claudia Müller, Bianca Dorn, Oliver Goldhardt, Janine Diehl-Schmid, Hans Förstl, Werner Steimer, Timo Grimmer   +12 more
doaj   +1 more source

Rivastigmine for ECT-induced cognitive adverse effects in late life depression (RECALL study): A multicenter, randomized, double blind, placebo-controlled, cross-over trial in patients with depression aged 55 years or older: Rationale, objectives and methods

Frontiers in Psychiatry, 2022
BackgroundCognitive side-effects are an important reason for the limited use of electroconvulsive therapy (ECT). Cognitive side-effects are heterogeneous and occur frequently in older persons.
Marieke J. Henstra, Marieke J. Henstra, Marieke J. Henstra, Thomas C. Feenstra, Thomas C. Feenstra, Rob M. Kok, Harm-Pieter Spaans, Eric van Exel, Eric van Exel, Eric van Exel, Eric van Exel, Annemiek Dols, Annemiek Dols, Annemiek Dols, Annemiek Dols, Annemiek Dols, Mardien Oudega, Mardien Oudega, Mardien Oudega, Mardien Oudega, Anton C. M. Vergouwen, Adriano van der Loo, Pierre M. Bet, Stephan A. Loer, Merijn Eikelenboom, Merijn Eikelenboom, Pascal Sienaert, Simon Lambrichts, Filip Bouckaert, Judith E. Bosmans, Judith E. Bosmans, Nathalie van der Velde, Nathalie van der Velde, Aartjan T. F. Beekman, Aartjan T. F. Beekman, Aartjan T. F. Beekman, Max L. Stek, Didi Rhebergen, Didi Rhebergen, Didi Rhebergen   +39 more
doaj   +1 more source

Hypotensive Episodes Precede Cognitive Fluctuations in Parkinson's Disease Dementia

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Cognitive fluctuations (CFs) are a disabling feature in Parkinson's disease dementia (PDD) and contribute to caregiver burden. The relationship between CFs and neurogenic orthostatic hypotension (nOH), a common autonomic complication in PDD, has not been adequately examined.
Jorge Patino, Kevin Duque, Jesus Abanto, Aaron Bloemer, Heba Deraz, Alberto J. Espay, Abhimanyu Mahajan   +6 more
wiley   +1 more source